New York, United States
Harmonic Discovery, founded in 2021 and headquartered in New York City, is a pioneering player in the Biotechnology and Health and Wellness industries. The company operates under the slogan: "Embedding the complexity of disease into the drug discovery process," aiming to revolutionize the current landscape of drug discovery.
Unlike traditional approaches that rely on the "one drug-one protein magic bullet" concept, Harmonic Discovery focuses on designing multi-specific therapeutics. This method targets several dysregulated proteins across distinct biological pathways, addressing the multifaceted nature of diseases like cancer and autoimmunity. The company builds a computational-experimental platform to enhance drug efficacy and safety.
The most recent investment round of $8.00M, a Seed Round completed on 08 September 2022, was backed by heavyweights including Y Combinator, Caffeinated Capital, Innovation Endeavors, 50Y, and Boom Capital Ventures. This strong coalition of investors underscores the growing confidence in Harmonic Discovery's innovative approach to drug discovery.
